Showing results (81-90 of 537) with videos related to
Sort By:
Pageof 54
Cancer Informatics|March 20, 2015
Identification of medium-sized copy number alterations in whole-genome sequencingHatice Gulcin Ozer, Aisulu Usubalieva, Adrienne Dorrance, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2007
Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemiaWilliam Blum, Rebecca B Klisovic, Bjoern Hackanson, et al.Blood Advances|February 25, 2020
Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801Guido Marcucci, Susan Geyer, Kristina Laumann, et al.The AAPS Journal|November 27, 2012
In vivo quantification of active decitabine-triphosphate metabolite: a novel pharmacoanalytical endpoint for optimization of hypomethylating therapy in acute myeloid leukemiaHongyan Wang, Ping Chen, Jiang Wang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2008
A phase I biological study of MG98, an oligodeoxynucleotide antisense to DNA methyltransferase 1, in patients with high-risk myelodysplasia and acute myeloid leukemiaRebecca B Klisovic, Wendy Stock, Spero Cataland, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2012
Bortezomib added to daunorubicin and cytarabine during induction therapy and to intermediate-dose cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502Eyal C Attar, Jeffrey L Johnson, Philip C Amrein, et al.Briefings in Bioinformatics|October 11, 2015
Statistical methods for detecting differentially methylated regions based on MethylCap-seq dataDeepak N Ayyala, David E Frankhouser, Javkhlan-Ochir Ganbat, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 26, 2008
Enzyme kinetics of GTI-2040, a phosphorothioate oligonucleotide targeting ribonucleotide reductaseXiaohui Wei, Guowei Dai, Zhongfa Liu, et al.Anticancer Research|February 13, 2010
Disulfide-linked liposomes: effective delivery vehicle for Bcl-2 antisense oligodeoxyribonucleotide G3139Wanlop Weecharangsan, Bo Yu, Shujun Liu, et al.The AAPS Journal|December 31, 2010
Biochemical modulation of aracytidine (Ara-C) effects by GTI-2040, a ribonucleotide reductase inhibitor, in K562 human leukemia cellsPing Chen, Josephine Aimiuwu, Zhiliang Xie, et al.Pageof 54